• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[P53家族蛋白为肺癌发生机制及临床治疗提供新见解]

[P53 family proteins provide new insights into lung carcinogenesis and clinical treatment].

作者信息

Huang Wenyan, Liu Kaishan

机构信息

Department of Pathology, Medical College, Ji'nan University, Guangzhou 510632, China.

出版信息

Zhongguo Fei Ai Za Zhi. 2013 Aug 20;16(8):422-6. doi: 10.3779/j.issn.1009-3419.2013.08.06.

DOI:10.3779/j.issn.1009-3419.2013.08.06
PMID:23945246
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6000662/
Abstract

The transcription activation of p53 plays an important role in the maintenance of genetic stability. P53 is an intensive study tumor suppressor, which has been called the "gene guider". The p53 family members p63, p73 have high homologous sequence with p53. Some of them can bind to the p53-responsive genes and transcript the downstream genes. Human lung cancer is one of the most common malignant tumors in the world. Abnormality of the p53 gene is the significant event in lung cancers, which leads to the poor prognosis and the resistance of chemotherapy. A deep understanding of the relationship between p53 family members and lung cancers can provide a more reasonably targeted clinical approach. This paper will focus on the special function of p53 family members in the development, chemosensitivity and target treatment of lung cancer.

摘要

p53的转录激活在维持遗传稳定性中起重要作用。p53是一个深入研究的肿瘤抑制因子,被称为“基因向导”。p53家族成员p63、p73与p53具有高度同源序列。其中一些成员可与p53反应基因结合并转录下游基因。肺癌是世界上最常见的恶性肿瘤之一。p53基因异常是肺癌中的重要事件,这导致预后不良和化疗耐药。深入了解p53家族成员与肺癌之间的关系可为临床提供更合理的靶向治疗方法。本文将聚焦于p53家族成员在肺癌发生、化疗敏感性及靶向治疗中的特殊作用。

相似文献

1
[P53 family proteins provide new insights into lung carcinogenesis and clinical treatment].[P53家族蛋白为肺癌发生机制及临床治疗提供新见解]
Zhongguo Fei Ai Za Zhi. 2013 Aug 20;16(8):422-6. doi: 10.3779/j.issn.1009-3419.2013.08.06.
2
P53 family: at the crossroads in cancer therapy.P53 家族:癌症治疗的十字路口。
Curr Med Chem. 2009;16(32):4328-44. doi: 10.2174/092986709789578196.
3
p73 tumor suppressor protein: a close relative of p53 not only in structure but also in anti-cancer approach?p73 肿瘤抑制蛋白:在结构上不仅与 p53 密切相关,而且在抗癌方法上也有相似之处?
Cell Cycle. 2010 Feb 15;9(4):720-8. doi: 10.4161/cc.9.4.10668. Epub 2010 Feb 16.
4
A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma.一种 microRNA 依赖的程序控制了人源和鼠源鳞状细胞癌中 p53 非依赖性存活和化疗敏感性。
J Clin Invest. 2011 Feb;121(2):809-20. doi: 10.1172/JCI43897.
5
Clinical implication of p53 mutation in lung cancer.肺癌中p53突变的临床意义
Mol Biotechnol. 2003 Jun;24(2):141-56. doi: 10.1385/MB:24:2:141.
6
Effects of p73 gene overexpression on apoptosis and chemosensitivity of human lung adenocarcinoma cell line A549.p73基因过表达对人肺腺癌细胞系A549凋亡及化疗敏感性的影响
Ai Zheng. 2006 Aug;25(8):925-32.
7
Chitinase 3 like 1 suppresses the stability and activity of p53 to promote lung tumorigenesis.几丁质酶 3 样蛋白 1 通过抑制 p53 的稳定性和活性促进肺肿瘤发生。
Cell Commun Signal. 2020 Mar 4;18(1):5. doi: 10.1186/s12964-019-0503-7.
8
Expression of the p53 family in lung cancer.p53家族在肺癌中的表达。
Anticancer Res. 2006 May-Jun;26(3A):1785-90.
9
p63 and p73: roles in development and tumor formation.p63和p73:在发育和肿瘤形成中的作用
Mol Cancer Res. 2004 Jul;2(7):371-86.
10
p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53.p73和p63是同四聚体,它们彼此之间能够发生微弱的异型相互作用,但与p53则不会发生这种作用。
J Biol Chem. 1999 Jun 25;274(26):18709-14. doi: 10.1074/jbc.274.26.18709.

引用本文的文献

1
Integration of multi-omics profiling reveals an epigenetic-based molecular classification of lung adenocarcinoma: implications for drug sensitivity and immunotherapy response prediction.多组学分析的整合揭示了基于表观遗传学的肺腺癌分子分类:对药物敏感性和免疫治疗反应预测的意义。
Front Pharmacol. 2025 Feb 19;16:1540477. doi: 10.3389/fphar.2025.1540477. eCollection 2025.
2
[Effects of tumor suppressor gene TCF21 on the proliferation, migration and apoptosis of A549 cells].肿瘤抑制基因TCF21对A549细胞增殖、迁移及凋亡的影响
Zhongguo Fei Ai Za Zhi. 2014 Apr;17(4):302-7. doi: 10.3779/j.issn.1009-3419.2014.04.03.

本文引用的文献

1
Allele specific gain-of-function activity of p53 mutants in lung cancer cells.肺癌细胞中 p53 突变体的等位基因特异性获得性功能。
Biochem Biophys Res Commun. 2012 Nov 9;428(1):6-10. doi: 10.1016/j.bbrc.2012.09.029. Epub 2012 Sep 16.
2
p53 Isoforms: An Intracellular Microprocessor?p53 异构体:一种细胞内微处理器?
Genes Cancer. 2011 Apr;2(4):453-65. doi: 10.1177/1947601911408893.
3
Docetaxel plus trans-tracheal injection of adenoviral-mediated p53 versus docetaxel alone in patients with previously treated non-small-cell lung cancer.多西紫杉醇联合经气管内注射腺病毒介导的 p53 与单纯多西紫杉醇治疗既往治疗的非小细胞肺癌患者的比较。
Cancer Gene Ther. 2011 Jun;18(6):444-9. doi: 10.1038/cgt.2011.15. Epub 2011 Apr 1.
4
PRIMA-1Met/APR-246 induces apoptosis and tumor growth delay in small cell lung cancer expressing mutant p53.PRIMA-1Met/APR-246 诱导表达突变型 p53 的小细胞肺癌细胞凋亡和肿瘤生长延迟。
Clin Cancer Res. 2011 May 1;17(9):2830-41. doi: 10.1158/1078-0432.CCR-10-3168. Epub 2011 Mar 17.
5
p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.p63 和 p73 异构体在非小细胞肺癌及相应形态正常肺组织中的表达。
J Thorac Oncol. 2011 Mar;6(3):473-81. doi: 10.1097/JTO.0b013e31820b86b0.
6
[Study on relationship between p63 expression and 3q27-q29 alteration in non-small cell lung cancer].
Zhongguo Fei Ai Za Zhi. 2004 Oct 20;7(5):419-22. doi: 10.3779/j.issn.1009-3419.2004.05.10.
7
[Effect of recombinant adenovirus-p53 on growth and chemosensitivity of human lung adenocarcinoma cell lines].重组腺病毒-p53对人肺腺癌细胞系生长及化疗敏感性的影响
Zhongguo Fei Ai Za Zhi. 2006 Apr 20;9(2):127-31. doi: 10.3779/j.issn.1009-3419.2006.02.06.
8
Increasing p53 protein sensitizes non-small cell lung cancer to paclitaxel and cisplatin in vitro.p53 蛋白表达增加可增强非小细胞肺癌对紫杉醇和顺铂的体外敏感性。
Anticancer Res. 2010 Sep;30(9):3557-64.
9
Second-line chemotherapy for small-cell lung cancer (SCLC).小细胞肺癌(SCLC)的二线化疗。
Cancer Treat Rev. 2011 Apr;37(2):143-50. doi: 10.1016/j.ctrv.2010.05.004. Epub 2010 Jun 26.
10
Clinical outcomes and correlates of TP53 mutations and cancer.TP53 基因突变与癌症的临床结局和相关性。
Cold Spring Harb Perspect Biol. 2010 Mar;2(3):a001016. doi: 10.1101/cshperspect.a001016.